<ul><li>Size of the site: 10,000 m²</li><li>production: 3,500 m²</li><li>packaging 5,500 m²</li><li>Analytics: 1,000 m²</li><li>External warehouse: 4,400 pallet places</li><li>FTE: 250</li><li>shifts: 24/5</li></ul>

<ul><li>Production of Solids<ul><li>Tablets</li><li>Filmcoated tablets</li><li>Sugar coated tablets</li><li>Hard gelatin capsules</li><li>Micro- and Low-dosed capsules</li><li>Dry powder inhalation capsules</li></ul></li><li>OEB 1-5, incl. narcotics and hormones</li><li>Quality control services</li></ul>

<ul><li>One stop shop from development to commercial productions</li><li>Full galenical and analytical development services for all type of solids</li></ul>

<ul><li>Tablets (blister)</li><li>Tablets (bottles)</li><li>Capsules (blister)</li><li>Integrated serialization &amp; aggregation</li></ul>

<ul><li>Manufacturing licenses<ul><li>EU GMP</li></ul></li><li>Non EU-GMP certificates<ul><li>US FDA</li><li>ANVISA</li><li>Belarusian MoH</li><li>Iranian MoH</li><li>Kenyan MoH</li><li>Korean MoH</li><li>Libyan MoH</li><li>Russian MoH</li><li>Turkish MoH</li><li>Ugandan MoH</li></ul></li></ul>

<ul><li>Rx</li><li>OTC</li><li>Controlled Substances</li></ul>

Technologies

Granulation
<ul><li>4 high shear mixers with vacuum drying 16 up to 400 kg</li><li>2 high shear mixers 70 kg</li><li>1 fluid bed dryer/granulator 100 kg</li><li>4 plough share blenders 50 – 400 kg</li><li>1 double-cone blender 50 kg </li></ul>
Compression
<ul><li>4 rotary tablet presses GEA Courtoy modul S</li><li>2 rotary tablet presses</li></ul>
Coating
<ul><li>2 Lödige LHC 190 (100 – 700 kg, film- and sugar coating)</li><li>1 Bohle BFC200 (200 kg, film coating)</li><li>6 Brucks sugar coating pans </li></ul>
Capsule filling
<ul><li>Turbula T10B</li><li>Cyclomix 15 L</li><li>dynaMix CM100</li><li>BTS 200</li><li>MG2 – Planeta 200</li></ul>
Packaging
<ul><li>6 blister lines</li><li>2 pouching machines for blisters/desiccant bags</li><li>1 bottle filling line (tablet counting machine)</li></ul>
Quality Control
<ul><li>&gt;25 HPLC systems</li><li>Dissolution test systems</li><li>Dry powder inhalation capsule test systems</li><li>Next generation impactor TSI /Copley </li><li>Various DUSA tubes</li><li>Stability chambers (all ICH-conditions) </li></ul>

Products

<ul><li>Sex hormones and modulators of the genital system</li><li>Inhalation capsules - respiratory diseases</li><li>Controlled substances</li><li>Psycholeptics</li><li>Thyroid hormones</li><li>Corticoides</li><li>Endocrine therapy</li><li>Immunosuppressants</li><li>Cardiac therapy</li><li>Anti-inflammatory and antirheumatic products</li></ul>

Münster

The Aenova site in Münster has special expertise in the development, production and packaging of low-dosed tablets and hard gelatine capsules containing highly potent APIs like hormones, hormone-related, corticoids, narcotics and other highly potent/low dosed APIs.

Münster - Aenova Group

employees

certifications & approvals

square meter

Tablet press Münster Aenova

Isolator Münster Aenova

Film and sugar coater Münster Aenova

Tablet counting machine Münster Aenova

Blister packaging line Münster Aenova

Processor Münster Aenova

High potent blisters Münster Aenova

Exterior view Münster Aenova

Aenova Site Muenster High-potent and low-dosed APIs

Facts

Location Münster, Germany 
Competence Center low-dosed high potent solids (hormones, hormone-like), low-dosed capsules

The Aenova site in Münster has special expertise in the development, production and packaging of low-dosed tablets and hard gelatine capsules containing highly potent APIs like hormones, hormone-related, corticoids, narcotics and other highly potent/low dosed APIs.
The site's long tradition in the field of contraceptives and narcotics since 1966 is today accompanied by production technologies for micro-dosed capsules, e.g. dry powder inhalation capsules.

Training is important to us: Aenova Münster at CoeMBO 2022

06/12/2022 - Training is important to us: Aenova Münster at CoeMBO 2022

Münster, 06/12/2022

Training is of great importance at Aenova. With over 80 trainees within the Aenova Group, vocational training for the next generation is an integral part at all Aenova locations.At the career information fair CoeMBO on November 12, 2022 in the school center of the city of Coesfeld, Aenova Münster was on site with a team and informed many young interested students about all topics related to training at one of the world's leading contract manufacturers for the pharmaceutical and healthcare industry. Aenova's Münster site focuses on the development, production and packaging of high-potency and/or low-dose tablets and, in particular, hormones, hormone-like substances and narcotics. Another focus is on production technologies for micro-dosed capsules, e.g. with dry powder for inhalation. Around 250 employees contribute to the success of the site. The following training courses are offered: Apprenticeship as chemical laboratory assistant (m/f/d), pharmaceutical assistant (m/f/d), industrial clerk (m/f/d), IT specialist for system integration (m/f/d). Currently, 9 trainees are employed at Aenova in Münster. "We are pleased to be able to offer young people in the region interesting apprenticeships every year. The pharmaceutical industry is characterized by very good job and career prospects," explains Michael Obermeier, Head of Human Resources in Münster. "At the same time, we work here for the health of patients worldwide. That, of course, is another very special motivation," Obermeier continues. The CoeMBO is a trade fair for career guidance, where young people from Münsterland and the surrounding area get the opportunity to get an overview of the possibilities after graduating from school. After a two-year break from Corona, the fair was held again this year in presence. <figure><img src="https://www.aenova-group.com/content/_medium/Messe_Gruppenfoto-MST.jpg" data-image="555374"><figcaption>Team Aenova Münster at training event</figcaption></figure>

Micro-dosed capsule filling and dry powder inhalation are key innovation topics at Aenova

26/10/2022 - Micro-dosed capsule filling and dry powder inhalation at Aenova

Münster, 26/10/2022

Dry powder inhalation using a DPI device (dry powder inhaler) is becoming more and more important for patient care in view of the worldwide increase in lung and respiratory diseases. The need for therapeutics for bronchial asthma and COPD (chronic obstructive pulmonary disease), for example, is also rising worldwide. Many of the therapies need to be used by patients for life, which underscores the need to make DPI cost-effectively available and easy for patients to use.The galenic formulation of the active ingredients is particularly challenging, as the inhalable aerosol particles must have an aerodynamic diameter of 1 to 5 µm over the entire shelf life of the product in order to ensure adequate pulmonary mobility. For this purpose, Aenova has a state-of-the-art DPI capsule production and proven expertise from development to commercial production. With state-of-the-art micro-dosing technology, Aenova ensures full scalability for DPI capsule products (flexible batch sizes from 0.5 kg to commercial sizes). In addition, there are product-specific analysis options according to EP / USP as well as specific blistering and combination packaging solutions. Together with the customer, Aenova creates a purposeful concept phase and a product design precisely tailored to the requirements - including analytical method development, ICH stability testing, development and validation of the manufacturing process to obtain a safe and stable effect of the drug product. The modern high-speed capsule filling machine at the Aenova site in Münster is suitable for product dosing in the range of 5 mg to 50 mg per capsule and is equipped with 100% control, which enables in-process control of each individual capsule and ensures the highest quality of the final low-dose product. If required, additional modular dosing units can be integrated to combine also different dosage forms, e.g. pellets and powder, tablets and pellets and other variants. "We are very proud to be able to offer such a comprehensive service from development to commercial production in the field of dry powder inhalation and micro-dosed capsule filling of highly potent active ingredients," says Dr. Gereon Rau, Team Lead - Capsule Technologies at Aenova. "Our innovative solutions and reliable production and delivery capabilities are of benefit to our customers in the pharmaceutical industry and, last but not least, to patients with respiratory diseases worldwide." 
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_Capsule-filling-machine.jpg" data-image="555136" alt="Mikrodosierte Kapselabfüllung"><figcaption>State-of-the-art capsule filling machine for low-dose capsule filling at the Aenova site in Münster (Photo: Aenova)</figcaption></figure>

Auf einen Blick

At a glance

Jan Kengelbach

Dr. Peter Waller

Dr Peter Waller

Tim Bauer

Anne-Sophie Bonte, Ph.D.

Florent Bordet, Ph.D.

Florent Bordet, Ph. D.

Neil Jones

Management

Aufsichtsrat

Supervisory Board

Bad Aibling

Carugate

Cornu

Feldkirchen

Greensboro

Gronau

Killorglin

Kirchberg

Latina

Marburg

Regensburg

Sisseln

Starnberg

Tittmoning

Standorte

Manufacturing Sites

Compliance

Nachhaltigkeit

Corporate Sustainability

Werte

Values

Ressourcen

Resources

Unternehmen

Company

Tablets

Hard Capsules

Effervescents, Lozenges, Chewables

High potent solids

Controlled release

Beta Lactam Antibiotics

Solida

Solids

Liquid Vials

Prefilled Syringes

Beta Lactams

Fill & Finish of Biologics

Sterile Technologien

Sterile Technologies

Non-Sterile Liquids

Ointments and creams

Suppositories

Semisolida & nicht sterile Flüssigkeiten

Semi-solids & Non sterile Liquids

Soft Gelatin Capsules

VegaGels®

Weichgelatine Kapseln

Softgel Capsules

Blister

Vials & Ampoules

Bottles & Tubes, Cans & Jars

Cartons & Boxes

Services

Verpackungs-Services

Packaging Services

Qualität

Quality

Pharmazeutische Fertigung

Pharmaceutical Manufacturing

Semisolids & Liquids

Soft Gel Capsules

Sterile Injectables

Entwicklung von Arzneimitteln

Drug Product Development

Analytische Entwicklung

Analytical Development

Clinical Trial Supply Management

Regulatorische Unterstützung

Regulatory Support

Technologie Transfer

Technology Transfer

Entwicklung & Technologie

Development & Technology Services

Haustiere

Companion Animals

Nutztiere

Farm Animals

Tiergesundheit

Animal Health

Investoren

Investor Relations

Arbeiten bei Aenova

Working at Aenova

Karrierestufen

Career Levels

Ihre Bewerbung bei Aenova

Your application at Aenova

Job Portal

Karriere

Career

News

Events

News & Events

Presse Portal

Press Portal

Münster

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News